Abstract:Synovial chondromatosis is a rare benign condition characterized by chondral proliferation from synovium forming loose bodies which can occur extra‐articularly and intra‐articularly. Surgical removal remains the mainstay of treatment for synovial chondromatosis. Due to the risk of recurrence, every case must be followed up with an MRI.
“…Surgical removal of calcified bodies is indicated in the presence of mechanical symptoms like locking. The diagnosis can be confirmed with histopathological features such as papillary hyperplasia of the synovium and multiple cartilaginous nodules of varying size with or without focal ossification 3–5. Definitive treatment is with total joint arthroplasty 1–5 7.…”
Section: Descriptionmentioning
confidence: 99%
“…The diagnosis can be confirmed with histopathological features such as papillary hyperplasia of the synovium and multiple cartilaginous nodules of varying size with or without focal ossification 3–5. Definitive treatment is with total joint arthroplasty 1–5 7. Osteochondromatosis has a favourable prognosis.…”
Section: Descriptionmentioning
confidence: 99%
“…Osteochondromatosis has a favourable prognosis. Potential complications of the osteochondromatosis include secondary osteoarthritis, recurrence and malignant transformation 1–7. Recurrence rate after definitive surgery is less than 10% 1.…”
Section: Descriptionmentioning
confidence: 99%
“…Synovial chondromatosis is a rare condition characterised by the development of foci of cartilage in the joint synovium and less often in tendon sheaths or bursae. [1][2][3][4][5] Osteochondromatosis refers to when these cartilaginous foci are calcified. [1][2][3][4][5] The condition usually presents in patients between 30 and 50 years of age.…”
Section: Descriptionmentioning
confidence: 99%
“…[1][2][3][4][5] Osteochondromatosis refers to when these cartilaginous foci are calcified. [1][2][3][4][5] The condition usually presents in patients between 30 and 50 years of age. 1 2 The knee is the most commonly affected joint (more than half of reported cases).…”
“…Surgical removal of calcified bodies is indicated in the presence of mechanical symptoms like locking. The diagnosis can be confirmed with histopathological features such as papillary hyperplasia of the synovium and multiple cartilaginous nodules of varying size with or without focal ossification 3–5. Definitive treatment is with total joint arthroplasty 1–5 7.…”
Section: Descriptionmentioning
confidence: 99%
“…The diagnosis can be confirmed with histopathological features such as papillary hyperplasia of the synovium and multiple cartilaginous nodules of varying size with or without focal ossification 3–5. Definitive treatment is with total joint arthroplasty 1–5 7. Osteochondromatosis has a favourable prognosis.…”
Section: Descriptionmentioning
confidence: 99%
“…Osteochondromatosis has a favourable prognosis. Potential complications of the osteochondromatosis include secondary osteoarthritis, recurrence and malignant transformation 1–7. Recurrence rate after definitive surgery is less than 10% 1.…”
Section: Descriptionmentioning
confidence: 99%
“…Synovial chondromatosis is a rare condition characterised by the development of foci of cartilage in the joint synovium and less often in tendon sheaths or bursae. [1][2][3][4][5] Osteochondromatosis refers to when these cartilaginous foci are calcified. [1][2][3][4][5] The condition usually presents in patients between 30 and 50 years of age.…”
Section: Descriptionmentioning
confidence: 99%
“…[1][2][3][4][5] Osteochondromatosis refers to when these cartilaginous foci are calcified. [1][2][3][4][5] The condition usually presents in patients between 30 and 50 years of age. 1 2 The knee is the most commonly affected joint (more than half of reported cases).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.